DigitalDX Ventures

“We have internally created a proprietary AI screening model for diligence, so, I mean, we probably see a hundred companies a month-ish. How do you whittle that down to the four that you're going to diligence? Right? So we have a quantitative screening that we …”

“We have a company that does an eye scan for Alzheimer's 10 years before you see it.”

“One of our companies does a urine test to determine if you're going to reject a kidney from transplant.”

“We do have a woman on every board of every company that we have just cause we do believe in the ability to have different points of view and our boards reflect The population that we're serving in the healthcare space.”

“We have about 25 experts in residence who have had great careers and really just believe in our thesis. So they help us source deals and then diligence deals. So, for example, the former chief scientist at Myriad Genetics one of our partners is David Kirk, who…”

“We want to own 10% at exit, and so we really believe, and we see so many amazing ideas coming out of labs.”

“We meet with all the leaders in healthcare, like we were, we're with Mayo, we're with Johns Hopkins, like all the different people leading the charge, and we actually just did something, ah, the Five Lakes, which is in the Five Lakes region for all the univers…”

“Personalized medicine is one of those things where it's a knowable fact. AI is one of the tools that will unleash that pattern matching for amounts of data sets, and we see it all the time in our companies. So many of them have to have thousands of samples to …”

“We have a company coming out of Oxford, Oxford Cancer Analytics, that can do a blood test and do a liquid biopsy with blood, so you don't have to go into the hospital and be admitted, you don't have to collapse your lung, and the ROI on that kind of a thing sa…”

“One of our portfolio companies, his name is Biosha. You may recall during COVID in New York City, they were testing the sewer water to see if COVID was in the water, and people were using that test to see if COVID was still spreading. So that came out of Weill…”

“Our thesis, our investment thesis, is that the human body is a big data problem”

“Part of what I see happening, and I don't necessarily think it's going to be a bust, but I do feel like there's going to be a much more verticalized focus on where AI helps the productivity the most”

“We are raising fund too, so I'm helping with fundraising.”

“DigitalDX is a pre-seed, seed investor. We focus on the intersection of AI and healthcare, and our main focus for an investment perspective is early non-invasive detection of large-scale diseases, cancers, Infectious diseases and cognitive diseases like Alzhei…”